NCT03324646View on ClinicalTrials.gov

Evaluation of a Novel PET Radioligand to Image Cyclooxygenase-1 (COX-1)

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

October 3, 2017

Primary Completion Date

September 11, 2020

Study Completion Date

January 30, 2024

Conditions
Normal Physiology
Interventions
DRUG

[11C]PS13

A novel PET ligand to selectively image COX-1

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH

NCT03324646 - Evaluation of a Novel PET Radioligand to Image Cyclooxygenase-1 (COX-1) | Biotech Hunter | Biotech Hunter